% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Bartolomucci:271286,
author = {Bartolomucci, Alessandro and Kane, Alice E and Gaydosh,
Lauren and Razzoli, Maria and McCoy, Brianah M and Ehninger,
Dan and Chen, Brian H and Howlett, Susan E and
Snyder-Mackler, Noah},
title = {{A}nimal {M}odels {R}elevant for {G}eroscience: {C}urrent
{T}rends and {F}uture {P}erspectives in {B}iomarkers, and
{M}easures of {B}iological {A}ging.},
journal = {The journals of gerontology / Series A},
volume = {79},
number = {9},
issn = {1079-5006},
address = {Oxford [u.a.]},
publisher = {Oxford Univ. Pr.},
reportid = {DZNE-2024-01025},
pages = {glae135},
year = {2024},
abstract = {For centuries, aging was considered inevitable and
immutable. Geroscience provides the conceptual framework to
shift this focus toward a new view that regards aging as an
active biological process, and the biological age of an
individual as a modifiable entity. Significant steps forward
have been made toward the identification of biomarkers for
and measures of biological age, yet knowledge gaps in
geroscience are still numerous. Animal models of aging are
the focus of this perspective, which discusses how
experimental design can be optimized to inform and refine
the development of translationally relevant measures and
biomarkers of biological age. We provide recommendations to
the field, including: the design of longitudinal studies in
which subjects are deeply phenotyped via repeated multilevel
behavioral/social/molecular assays; the need to consider
sociobehavioral variables relevant for the species studied;
and finally, the importance of assessing age of onset,
severity of pathologies, and age-at-death. We highlight
approaches to integrate biomarkers and measures of
functional impairment using machine learning approaches
designed to estimate biological age as well as to predict
future health declines and mortality. We expect that
advances in animal models of aging will be crucial for the
future of translational geroscience but also for the next
chapter of medicine.},
subtyp = {Review Article},
keywords = {Biomarkers / Animals / Aging: physiology / Models, Animal /
Geroscience / Humans / Animal model (Other) / Biomarkers
(Other) / Frailty (Other) / Senescence (Other) / Biomarkers
(NLM Chemicals)},
cin = {AG Ehninger},
ddc = {570},
cid = {I:(DE-2719)1013005},
pnm = {352 - Disease Mechanisms (POF4-352)},
pid = {G:(DE-HGF)POF4-352},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:39126297},
pmc = {pmc:PMC11316208},
doi = {10.1093/gerona/glae135},
url = {https://pub.dzne.de/record/271286},
}